Fig. 1From: Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infectionThe rate of positive serum RASSF1A methylation in the HCC, LC, CHB and healthy control groups. The positive rate was 64.2 % (122/190), 17.5 % (20/114), 5.0 % (6/120) and 0 (0/160), respectively; P * < 0.01 versus CHB; P ** < 0.001 versus LC, CHBBack to article page